Management of differentiated thyroid cancer with rising thyroglobulin and negative diagnostic radioiodine whole body scan.

@article{Chao2010ManagementOD,
  title={Management of differentiated thyroid cancer with rising thyroglobulin and negative diagnostic radioiodine whole body scan.},
  author={M. Chao},
  journal={Clinical oncology (Royal College of Radiologists (Great Britain))},
  year={2010},
  volume={22 6},
  pages={
          438-47
        }
}
  • M. Chao
  • Published 2010
  • Medicine
  • Clinical oncology (Royal College of Radiologists (Great Britain))
  • BACKGROUND Differentiated thyroid carcinoma (DTC) with rising thyroglobulin (Tg) level and negative radioiodine whole body scan results has been observed in follow-up studies. The management of this condition remains controversial. Most studies support blind (131)I treatment while others oppose this approach. AIMS To assess the effects of (131)I therapy for DTC with rising Tg and negative scan results. SELECTION CRITERIA Randomised controlled clinical trials, prospective controlled clinical… CONTINUE READING
    Second Radioiodine Treatment: Limited Benefit for Differentiated Thyroid Cancer With Locoregional Persistent Disease
    • 5
    • Highly Influenced
    • Open Access

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 63 REFERENCES